Anticancer drugs could make immunotherapies more effective

byWeill Cornell Medical CollegePretreatment with EZH2 inhibitor (top right) leads to higher recruitment of CAR-T cells (red) into the lymph node tumor compared with control (top left). Pretreatm

Updated on: December 21,2024

Anticancer drugs could make immunotherapies more effective

byWeill Cornell Medical CollegePretreatment with EZH2 inhibitor (top right) leads to higher recruitment of CAR-T cells (red) into the lymph node tumor compared with control (top left). Pretreatm

Updated on:December 21,2024

Lung cancer cells can go 'off grid' and develop their own electrical network within the tumor, study shows

Updated on: March 27,2025

Lung cancer cells can go 'off grid' and develop their own electrical network within the tumor, study shows

Updated on:March 27,2025

Annual report reveals more cancers are being treated with personalized therapies before surgery

byAmerican College of SurgeonsWhat to know about breast cancer according to the National Cancer Database. Credit: American College of SurgeonsBreast, bladder, and pancreatic cancers are increasi

Updated on: December 21,2024

Annual report reveals more cancers are being treated with personalized therapies before surgery

byAmerican College of SurgeonsWhat to know about breast cancer according to the National Cancer Database. Credit: American College of SurgeonsBreast, bladder, and pancreatic cancers are increasi

Updated on:December 21,2024

Research reveals how fructose in diet enhances tumor growth

byWashington University in St. LouisCredit: CC0 Public DomainFructose consumption has increased considerably over the past five decades, largely due to the widespread use of high-fructose corn s

Updated on: December 21,2024

Research reveals how fructose in diet enhances tumor growth

byWashington University in St. LouisCredit: CC0 Public DomainFructose consumption has increased considerably over the past five decades, largely due to the widespread use of high-fructose corn s

Updated on:December 21,2024

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1

Updated on: January 22,2025

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1

Updated on:January 22,2025

Cancer diagnoses and deaths are declining in Appalachia but remain significantly higher compared to other US regions

Updated on: March 27,2025

Cancer diagnoses and deaths are declining in Appalachia but remain significantly higher compared to other US regions

Updated on:March 27,2025

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patientsby NRG OncologyCredit: Pixabay/CC0 Public DomainRecent results from the Phase III NRG-RT

Updated on: January 21,2025

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patientsby NRG OncologyCredit: Pixabay/CC0 Public DomainRecent results from the Phase III NRG-RT

Updated on:January 21,2025

Natural killer cells offer hope for hard-to-treat pediatric sarcomas

byUniversity of QueenslandEphrin type-A receptor-2 (EphA2) and natural killer (NK) cell infiltration correspond with sarcoma survival. Credit:Clinical and Translational Medicine(2025

Updated on: February 20,2025

Natural killer cells offer hope for hard-to-treat pediatric sarcomas

byUniversity of QueenslandEphrin type-A receptor-2 (EphA2) and natural killer (NK) cell infiltration correspond with sarcoma survival. Credit:Clinical and Translational Medicine(2025

Updated on:February 20,2025

Reducing dose of popular blood thinners may limit risk of future bleeding, study finds

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainFor people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospi

Updated on: January 17,2025

Reducing dose of popular blood thinners may limit risk of future bleeding, study finds

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainFor people taking popular blood thinners after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospi

Updated on:January 17,2025

Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

by Alan Dove,Cornell UniversityA clump of prostate cancer cells. The blue-green cells are growing, whereas the pink ones are dying by programmed cell death (apoptosis). Credit: Dave McCarthy and

Updated on: January 23,2025

Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

by Alan Dove,Cornell UniversityA clump of prostate cancer cells. The blue-green cells are growing, whereas the pink ones are dying by programmed cell death (apoptosis). Credit: Dave McCarthy and

Updated on:January 23,2025

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi

Updated on: January 22,2025

Reactive cysteines on peptide antigens may unlock new cancer immunotherapy possibilities

by Olivia Dimmer,Northwestern UniversityDevelopment of cell-impermeable cysteine-reactive probes. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54139-8Northwestern Medi

Updated on:January 22,2025

MAGE-A4 protein promotes tumor progression by suppressing immune responses, mouse study finds

Updated on: March 27,2025

MAGE-A4 protein promotes tumor progression by suppressing immune responses, mouse study finds

Updated on:March 27,2025